Sanderling Ventures
Venture capitalSan Mateo · Seed–Late Stage · 9 people tracked
Also known as SANDERLING MANAGEMENT COMPANY, LLC
Investment thesis
Sanderling invests in and helps build biomedical companies, combining a specialized investment focus with active management and a long-term commitment. The firm emphasizes close working partnerships with entrepreneurs to build significant companies and generate strong returns for both founders and investors. Areas of specialization include small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website
What they invest in
from 36 of 75 portfolio companiesBiotech ×23Medical Devices ×20Healthtech ×17Digital Health ×3AI & Machine Learning ×2Hardware ×2Advanced Manufacturing ×1Circular Economy ×1
HQs:United States×19France×1
Investments · 75 tracked
founders shown can be your intro pathBiotechMiramar, US
Hing C Wong(Executive Officer, Director)Lee Flowers(Executive Officer)Rebecca Byam(Executive Officer)Peter Rhode(Executive Officer)Peter Sun(Director)Fred M. Middleton(Director)
Board seatFred Middleton· per SEC Form D · $16M raise · filed Oct 2020
Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
HealthtechMedical Devices
BiotechLa Jolla, US
Eric W. Roberts(Executive Officer, Director)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Kenneth A. Stauderman(Executive Officer)Sudarshan Hebbar(Executive Officer)Eric Bjerkholt(Director)
St.Louis, US
David L. Fischel(Executive Officer, Director)Kimberly R. Peery(Executive Officer, Director)Duane DeSisto(Director)Arun Menawat(Director)David Fischel(Director)Robert J. Messey(Director)
BiotechLa Jolla, US
Kenneth A. Stauderman(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Daniel Geffken(Executive Officer)Sudarshan Hebbar(Executive Officer)Eric W. Roberts(Executive Officer)Michael J. Dunn(Executive Officer, Director)
Board seatFred MiddletonRobert G. McNeil· per SEC Form D · $17.2M raise · filed May 2020
San Diego, US
Board seatRobert G. McNeil· per SEC Form D · $52.6M raise · filed Jul 2017
BiotechMiramar, US
Hing C Wong(Executive Officer, Director)Adam Waldman(Director)Fred Middleton(Director)C. Boyder Gray(Director)Peter Rhode(Executive Officer)
Artielle Immunotherapeutics develops DRhQ, a therapeutic platform targeting CD74 receptors to treat neuroinflammatory conditions like progressive multiple sclerosis and advanced cancers.
AI & Machine LearningBiotechMedical DevicesPortland, US
Asteres develops ScriptCenter automated kiosks and lockers that provide 24/7 secure pickup and payment for pharmacist-filled prescriptions and healthcare products.
Digital HealthHardwareHealthtech
CalciMedica is a clinical-stage biopharmaceutical company developing therapies that inhibit CRAC calcium channels to address acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.
BiotechHealthtechMedical Devices
Philips provides cardiac monitoring and diagnostic solutions that connect patient monitoring across hospital and home settings.
Digital HealthHealthtechMedical Devices
Received FDA approval for TEMBEXA (brincidofovir) to treat smallpox.
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical Devices
DalCor Pharmaceuticals develops dalcetrapib, a precision medicine treatment for cardiovascular disease targeting patients with a specific genetic marker (ADCY9 AA genotype).
BiotechDigital HealthMedical Devices
Dendreon develops and manufactures cellular immunotherapies, including PROVENGE (sipuleucel-T), an FDA-approved cellular immunotherapy for prostate cancer patients.
BiotechHealthtech
Skyepharma is a French contract development and manufacturing organization (CDMO) specializing in complex oral solid dosage forms, including modified-release tablets, highly potent APIs, and orphan drugs, serving pharmaceutical companies worldwide from early-stage development through commercial manufacturing.
Advanced ManufacturingBiotechMedical DevicesFrance, FR
DePuy Synthes develops orthopedic medical devices and solutions including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine products, along with digital surgery technologies.
HealthtechMedical Devices
Suwanee, US
Matthew G. Molchan(Executive Officer, Director)David Noble(Executive Officer)Jeffrey E. Eberwein(Director)John W. Sayward(Director)Michael A. Cunnion(Director)Mitchell I. Quain(Director)
Digirad manufactures portable nuclear medicine imaging cameras for cardiology and general nuclear imaging applications.
HardwareMedical Devices
Dynavax is a biopharmaceutical company that develops and commercializes novel vaccines using adjuvant technology to protect against infectious diseases.
Biotech
BiotechMedical Devices
Developing therapies for congenital disorders of glycosylation combining replacement therapies with intracellular delivery vehicles.
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.
Biotech
Steven Axon(Chief Executive Officer)Hicham Alaoui(Chief Scientific Officer)Rose Marino(Chief Medical Officer)Peter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)
Eden Prairie, US
Bobak Azamian(Executive Officer, Director)Tony Vrba(Executive Officer)Kevin Hykes(Executive Officer, Director)Kirk Nielsen(Director)
Metavention develops a treatment that targets the sympathetic nervous system to address high blood pressure and metabolic diseases using neuromodulation technology.
Medical Devices
Pacira develops non-opioid therapies and advanced treatments for musculoskeletal and chronic pain management, including gene therapy research.
BiotechHealthtechMedical Devices
San Jose, US
Robert M Abrams(Executive Officer, Director)Matt Jenusaitis(Director)Muscarella Thomas(Executive Officer)Timothy C. Mills(Director)
Regeneron discovers, develops, and manufactures biologics and genetic medicines for treating serious diseases including metabolic disorders, ophthalmology conditions, and rare diseases.
BiotechHealthtechMedical DevicesTarrytown, US
Sotera Wireless manufactures the ViSi Mobile System, a wearable patient monitoring platform that continuously tracks vital signs including blood pressure, oxygen saturation, heart rate, and ECG in general hospital care settings.
AI & Machine LearningHealthtechMedical Devices
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Sanderling Ventures invest at?
- Sanderling Ventures invests at the Seed, Series A, Late Stage stages.
- What is Sanderling Ventures's typical check size?
- Sanderling Ventures typically writes checks of $50K – $1M.
- What sectors does Sanderling Ventures focus on?
- Sanderling Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sanderling Ventures located?
- Sanderling Ventures is headquartered in San Mateo, US.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.